N | % | |
---|---|---|
Age (years) | ||
Median | 53 | |
Range | 31–73 | |
Sex | ||
Male | 5 | 11.4 |
Female | 39 | 88.6 |
Primary site of disease | ||
Uterus | 24 | 54.5 |
Retroperitoneum | 7 | 15.9 |
Other | 7 | 15.9 |
Extremity | 2 | 4.5 |
Vascular | 2 | 4.5 |
Thoracic | 1 | 2.3 |
Not known | 1 | 2.3 |
Disease type | ||
Locally advanced | 5 | 11.4 |
Metastatic | 39 | 88.6 |
Tumour grade | ||
Grade 1 | 6 | 13.6 |
Grade 2 | 10 | 22.7 |
Grade 3 | 23 | 52.3 |
Not known | 5 | 11.4 |
Site of metastases | ||
Lung | 31 | 70.4 |
Liver | 17 | 38.6 |
Soft tissue | 17 | 38.6 |
Viscera | 6 | 13.6 |
Bone | 4 | 9.1 |
None | 5 | 11.3 |
Number of metastatic sites | ||
0 | 5 | 11.3 |
1 | 16 | 26.4 |
2 | 13 | 29.5 |
3 | 8 | 18.2 |
4 | 2 | 4.5 |
Previous radiotherapy | ||
None | 30 | 68.2 |
Pelvic | 9 | 20.5 |
Other site | 5 | 11.4 |
Previous surgery | ||
Yes | 36 | 81.8 |
No | 8 | 18.2 |